Vicki L Sato insider trades

Open-market stock purchases and sales by Vicki L Sato, Director at Allogene Therapeutics, Inc, from SEC Form 4 filings since Feb 1, 2010.

Recent trades

DateStockTradeValue
Jun 18, 2026ALLO Allogene Therapeutics, IncBought (not open market)—
May 1, 2026VIR Vir Biotechnology, IncSold$221K
Apr 1, 2026VIR Vir Biotechnology, IncSold$200K
Mar 2, 2026VIR Vir Biotechnology, IncSold$207K
Mar 2, 2026VIR Vir Biotechnology, IncSold$2K
Feb 24, 2026VIR Vir Biotechnology, IncSold$411K
Feb 24, 2026VIR Vir Biotechnology, IncSold$2.1K
Feb 24, 2026VIR Vir Biotechnology, IncBought (not open market)—
Feb 2, 2026VIR Vir Biotechnology, IncSold$170K
Jan 2, 2026VIR Vir Biotechnology, IncSold$130K
Dec 1, 2025VIR Vir Biotechnology, IncSold$132K
Nov 3, 2025VIR Vir Biotechnology, IncSold$124K

Companies traded

  • ALLO Allogene Therapeutics, Inc: other filings, last Jun 18, 2026
  • VIR Vir Biotechnology, Inc: 53 sales, last May 1, 2026
  • DNLI Denali Therapeutics Inc: 49 sales, last Jan 2, 2025
  • AKUS Akouos, Inc: other filings, last Dec 1, 2022
  • BMY Bristol Myers Squibb Co: other filings, last Feb 1, 2021
  • BWA Borgwarner Inc: other filings, last Apr 29, 2020
  • SYRS Syros Pharmaceuticals, Inc: other filings, last Jun 11, 2019
  • PKI Perkinelmer Inc: 8 sales, last Feb 9, 2017
  • ALNY Alnylam Pharmaceuticals, Inc: other filings, last Jun 2, 2010

Get free alerts when Vicki L Sato files a new trade →